{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T19:41:19Z","timestamp":1760384479342},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.ijantimicag.2005.02.012","type":"journal-article","created":{"date-parts":[[2005,5,15]],"date-time":"2005-05-15T11:13:40Z","timestamp":1116155620000},"page":"479-487","source":"Crossref","is-referenced-by-count":7,"title":["Bactericidal activity of oral \u03b2-lactam antibiotics in plasma and urine versus isogenic Escherichia coli strains producing broad- and extended-spectrum \u03b2-lactamases"],"prefix":"10.1016","volume":"25","author":[{"given":"Branka","family":"Bedenic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmina","family":"Vranes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Suto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zivojin","family":"Zagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2005.02.012_bib1","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/CMR.14.4.933-951.2001","article-title":"Extended-spectrum \u03b2-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat","volume":"14","author":"Bradford","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2005.02.012_bib2","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1128\/AAC.34.9.1783","article-title":"In vitro activities of 15 oral \u03b2-lactams against Klebsiella pneumoniae harboring new extended-spectrum \u03b2-lactamases","volume":"34","author":"Kitzis","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 3","key":"10.1016\/j.ijantimicag.2005.02.012_bib3","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1007\/BF01644637","article-title":"Antibakterielle aktivitat und \u03b2-laktamase-stabilitat von elf oralcephalosporinen","volume":"18","author":"Bauernfeind","year":"1990","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2005.02.012_bib4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000238572","article-title":"Comparable evaluation of orally active \u03b2-lactam compounds in ampicillin-resistant Gram-positive and Gram-negative rods: role of \u03b2-lactamases on resistance","volume":"34","author":"Cullmann","year":"1988","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2005.02.012_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000238173","article-title":"Interactions of antimicrobial drugs and combined phagocytic\/serum bactericidal activity of defibrinated human blood against Serratia marcescens. III. \u03b2-Lactam antibiotics and fosfomycin","volume":"29","author":"Traub","year":"1983","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2005.02.012_bib6","unstructured":"National Committee for Clinical Laboratory Standards (NCCLS). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5 and informational supplement M100-S10. National Committee for Clinical Laboratory Standards, Wayne, PA, 2000."},{"key":"10.1016\/j.ijantimicag.2005.02.012_bib7","first-page":"651","article-title":"Comparative activity of cefepime, ceftazidime and imipenem in a mouse infection caused by Klebsiella pneumoniae producing a broad spectrum \u03b2-lactamase","volume":"46","author":"Ronco","year":"1998","journal-title":"Pathol Biol"},{"key":"10.1016\/j.ijantimicag.2005.02.012_bib8","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1128\/AAC.47.11.3506-3514.2003","article-title":"Extended-spectrum \u03b2-lactamases-producing Enterobacteriaceae in community and private health care centers","volume":"47","author":"Arpin","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.02.012_bib9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2165\/00003495-199039020-00008","article-title":"Amoxicillin\/clavulanic acid: an update of its antibacterial activity, pharmacokinetic properties and therapeutic use","volume":"39","author":"Todd","year":"1990","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2005.02.012_bib10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/jac\/16.4.491","article-title":"Pharmacokinetics of clavulanic acid, given in combination with amoxycillin, in volunteers","volume":"16","author":"Nilssson-Ehle","year":"1985","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. F","key":"10.1016\/j.ijantimicag.2005.02.012_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jac\/26.suppl_E.13","article-title":"The pharmacokinetics of the oral cephalosporins\u2014a review","volume":"26","author":"Wise","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.02.012_bib12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0140-6736(82)91103-5","article-title":"Penicillins and cephalosporins: antimicrobial and pharmacological properties","volume":"17","author":"Wise","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2005.02.012_bib13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/AAC.25.1.78","article-title":"Pharmacology of cefuroxime as the 1-acetoxyethyl ester in volunteers","volume":"25","author":"Harding","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2005.02.012_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jac\/dkf803","article-title":"Pharmacokinetics and pharmacodynamics of oral \u03b2-lactam antibiotics as a two-dimensional approach to their efficacy","volume":"50","author":"Auckenthaler","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.02.012_bib15","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1469-0691.1998.tb00083.x","article-title":"Bactericidal activity of gatifloxacin in plasma and urine","volume":"4","author":"Wise","year":"1998","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2005.02.012_bib16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/jac\/30.5.567","article-title":"Optimal dosage of \u03b2-lactam antibiotics: time above the MIC and inoculum effect","volume":"30","author":"Soriano","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.02.012_bib17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000220669","article-title":"Studies on the interaction between serum bactericidal activity and antibiotics in vitro","volume":"15","author":"Traub","year":"1970","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2005.02.012_bib18","series-title":"Urinary tract infections","first-page":"251","article-title":"Overview of therapy of acute urinary tract infections","author":"Johnson","year":"1998"},{"key":"10.1016\/j.ijantimicag.2005.02.012_bib19","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.ijantimicag.2003.09.006","article-title":"Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral dose","author":"Boy","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2005.02.012_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0924-8579(98)00014-4","article-title":"Urinary bactericidal activity and pharmacokinets of enoxacin versus norfloxacin in healthy volunteers after a single oral dose","volume":"10","author":"Well","year":"1998","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2005.02.012_bib21","first-page":"34","article-title":"Urinary tract infections: traditional pharmacologic therapies","volume":"113","author":"Lindsay","year":"2002","journal-title":"Am J Med"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857905000452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857905000452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T13:20:10Z","timestamp":1548508810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857905000452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0924857905000452"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2005.02.012","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}